Patent Assignment
Reel/Frame 064961/0567
Release of Security Interest
Recorded: 2023-09-20
Pages: 14
Assignor
HAMILTON SA LLC
Executed: 2023-09-18
Assignees
HELSINN HEALTHCARE SA
VIA PIAN SCAIROLO, LUGANO, SWITZERLAND
HELSINN THERAPEUTICS (U.S.), INC.
200 WOOD AVENUE SOUTH, SUITE 100, ISELIN, NEW JERSEY, 08830
HELSINN BIREX PHARMACEUTICALS LIMITED
15 DAMASTOWN RD, MULHUDDART, DUBLIN, IRELAND
Covered Properties
(73)
Physiologically Balanced Injectable Formulations of Fosnetupitant
Fumarate Salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea, Methods of Preparation, and Uses Thereof
Medical Treatments Based on Anamorelin
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
Crystalline Forms of an Nk-1 Antagonist
Methods of Manufacturing Anamorelin Tablets Having Improved Stability
Application:
17/634,616 →
Publication:
US 2022/0323430
Use of Anamorelin to Treat Cancer-Related Fatigue
Application:
63/212,148 →
Use of Anamorelin to Treat Cancer-Related Fatigue
Application:
17/838,308 →
Publication:
US 2022/0401429
New Centrally-Active Ghrelin Agonist and Medical Uses Thereof
Physiologically Balanced Injectable Formulations of Fosnetupitant
Process for the Synthesis of Substituted Chloromethyl Dialkylphosphates
Methods for Treating Skin Disorders with a Topical Composition of Bis-(2-Chloroethyl)Methylamine
Application:
15/804,804 →
Publication:
US 2018/0125797
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Substituted 4-Phenyl Pyridines Having Anti-Emetic Effect
Patent:
8,426,450 →
Application:
13/478,361 →
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
Asymmetric Ureas and Medical Uses Thereof
Liquid Pharmaceutical Formulations of Palonosetron
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
Liquid Pharmaceutical Formulations of Palonosetron
4-(5-(2-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-N,2-DIMETHYLPROPANAMIDO)-4-(o-TOLYL)PYRIDIN-2-YL)-1-METHYL-1-((PHOSPHONOOXY)METHYL)PIPERAZIN-1-IUM AS A NEUROKININ RECEPTOR MODULATOR
Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Asymmetric Piperidinyl-Substituted Ureas as Medicines
Medical Treatments Based on Anamorelin
Asymmetric Ureas and Medical Uses Thereof
Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content
Substituted Piperaziniums for the Treatment of Emesis
Substituted Asymmetric Ureas as Modulators of Ghrelin Receptor Activity
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
Crystalline Forms of an NK-1 Antagonist
Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content
Crystal Forms of Anamorelin
Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content
Crystalline Forms of Fosnetupitant
SOLUTION COMPRISING THE CHLORIDE HYDROCHLORIDE SALT OF 4-(5-(2-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-N,2-DIMETHYLPROPANAMIDO)-4-(o-TOLYL)PYRIDIN-2-YL)-1-METHYL-1-((PHOSPHONOOXY)METHYL)PIPERAZIN-1-IUM (FOSNETUPITANT) AND PALONOSETRON HYDROCHLORIDE IN COMBINATION WITH DEXAMETHASONE AS A NEUROKININ RECEPTOR MODULATOR
Crystalline Forms of an NK-1 Antagonist
Medical Treatments Based on Anamorelin
Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content
Asymmetric Ureas and Medical Uses Thereof
Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof
Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content
Substituted Asymmetric Ureas as Modulators of Ghrelin Receptor Activity
Physiologically Balanced Injectable Formulations of Fosnetupitant
Crystalline Forms of an Nk-1 Antagonist
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content
Fumarate Salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl) urea, Methods of Preparation, and Uses Thereof
Substituted Piperaziniums for the Treatment of Emesis
Medical Treatments Based on Anamorelin
Crystalline Forms of an Nk-1 Antagonist
Fosnetupitant Chloride Hydrochloride Having Improved Stability
Crystal Forms of (3R)-1-(2-Methylalanyl-D-Tryptophyl)-3-(Phenylmethyl)-3-Piperidinecarboxylic Acid 1,2,2-Trimethylhydrazide
Crystal Forms of (3R)-1-(2-Methylalanyl-D-Tryptophyl)-3-(Phenylmethyl)-3-Piperidinecarboxylic Acid 1,2,2-Trimethylhydrazide
Methods of Treating Emesis
Stabilized Compositions of Volatile Alkylating Agents and Methods of Using Thereof
Stabilized Compositions of Alkylating Agents and Methods of Using Same
Stabilized Compositions of Volatile Alkylating Agents and Methods of Using Thereof
Stabilized Compositions of Alkylating Agents and Methods of Using Same
Stabilized Compositions of Volatile Alkylating Agents and Methods of Using Thereof
Stabilized Compositions of Volatile Alkylating Agents and Methods of Using Thereof
Stabilized Compositions of Volatile Alkylating Agents and Methods of Using Thereof
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 21, 2006
From: CALDERARI, GIORGIO; BONADEO, DANIELE; CANNELLA, ROBERTA; BRAGLIA, ENRICO
To: HELSINN HEALTHCARE SA
Reel/Frame 017831/0234 →
Assignment of Assignor's Interest
Dec 6, 2010
From: MIKSZTAL, ANDREW; MALEFYT, THOMAS; LEE, KATHLEEN M.
To: ROCHE PALO ALTO LLC
Reel/Frame 025450/0180 →
Assignment of Assignor's Interest
Feb 16, 2011
From: CALDERARI, GIORGIO; BONADEO, DANIELE; CANNELLA, ROBERTA; BRAGLIA, ENRICO
To: HELSINN HEALTHCARE SA
Reel/Frame 025819/0244 →
Assignment of Assignor's Interest
Feb 16, 2011
From: MIKSZTAL, ANDREW; MALEFYT, THOMAS; LEE, KATHLEEN M.
To: ROCHE PALO ALTO LLC
Reel/Frame 025819/0334 →
Assignment of Assignor's Interest
Feb 16, 2011
From: CALDERARI, GIORGIO; BONADEO, DANIEL; BRAGLIA, ENRICO; BRAGLIA, RICCARDO
To: HELSINN HEALTHCARE SA
Reel/Frame 025816/0283 →
Assignment of Assignor's Interest
Feb 16, 2011
From: MIKSZTAL, ANDREW; MALEFYT, THOMAS; LEE, KATHLEEN M.
To: ROCHE PALO ALTO LLC
Reel/Frame 025816/0579 →
Assignment of Assignor's Interest
Sep 5, 2012
From: CALDERARI, GIORGIO; BONADEO, DANIEL; CANNELLA, ROBERTA; BRAGLIA, ENRICO
To: HELSINN HEALTHCARE SA
Reel/Frame 028899/0100 →
Assignment of Assignor's Interest
Nov 15, 2012
From: MIKSZTAL, ANDREW; MALEFYT, THOMAS; LEE, KATHLEEN M.
To: ROCHE PALO ALTO LLC
Reel/Frame 029302/0296 →
Assignment of Assignor's Interest
Nov 28, 2012
From: FADINI, LUCA; MANINI, PETER; PIETRA, CLAUDIO; GIULIANO, CLAUDIO
To: HELSINN HEALTHCARE SA
Reel/Frame 029365/0544 →
Assignment of Assignor's Interest
May 23, 2013
From: CALDERARI, GIORGIO; BONADEO, DANIELE; CANNELLA, ROBERTA; MACCIOCCHI, SIMONE
To: HELSINN HEALTHCARE SA
Reel/Frame 030478/0960 →
Assignment of Assignor's Interest
May 23, 2013
From: MACCIOCCHI, SIMONE; MACCIOCCHI, GIULIO
To: HELSINN HEALTHCARE SA
Reel/Frame 030478/0304 →
Assignment of Assignor's Interest
May 23, 2013
From: MIKSZTAL, ANDREW; MALEFYT, THOMAS; LEE, KATHLEEN M.
To: ROCHE PALO ALTO LLC
Reel/Frame 030479/0001 →
Assignment of Assignor's Interest
May 11, 2016
From: ROCHE PALO ALTO LLC
To: HELSINN HEALTHCARE SA
Reel/Frame 038544/0269 →
Assignment of Assignor's Interest
Nov 14, 2018
From: CALDERARI, GIORGIO; BONADEO, DANIEL; CANNELLA, ROBERTA; BRAGLIA, ENRICO
To: HELSINN HEALTHCARE SA
Reel/Frame 047498/0871 →
Assignment of Assignor's Interest
Nov 14, 2018
From: MIKSZTAL, ANDREW; MALEFYT, THOMAS; LEE, KATHLEEN M
To: ROCHE PALO ALTO LLC
Reel/Frame 047498/0886 →
Patent Co-Ownership Agreement
Nov 14, 2018
From: HELSINN HEALTHCARE SA
To: HELSINN ADVANCED SYNTHESIS SA; HELSINN BIREX PHARMACEUTIALS LTD.; HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 047534/0024 →
Corrective Assignment to Correct the 1. Spelling of Assignee Name Helsinn Birex Pharmaceuticals Ltd.; 2. Addresses of Assignees Previously Recorded on Reel 047534 Frame 0024. Assignor(S) Hereby Confirms the Patent Co-Ownership Agreement.
Nov 21, 2018
From: HELSINN HEALTHCARE SA
To: HELSINN ADVANCED SYNTHESIS SA; HELSINN BIREX PHARMACEUTICALS, LTD.; HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 047617/0285 →
Assignment of Assignor's Interest
Mar 26, 2019
From: KRAUSBAUER, ETIENNE; LAMBERT, OLIVIER; NAUD, FREDERIC; RAYES, DALIA
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 048705/0187 →
Assignment of Assignor's Interest
Aug 9, 2019
From: ACTELION PHARMACEUTICALS LTD
To: HELSINN BIREX PHARMACEUTICALS LIMITED
Reel/Frame 050008/0111 →
Assignment of Assignor's Interest
Sep 13, 2020
From: VENTURINI, ALESSIO; CANNELLA, ROBERTA
To: HELSINN HEALTHCARE SA
Reel/Frame 053754/0038 →
Assignment of Assignor's Interest
Feb 4, 2021
From: HELSINN THERAPEUTICS (US) INC; HELSINN ADVANCED SYNTHESIS SA
To: HELSINN HEALTHCARE SA
Reel/Frame 055145/0557 →
Assignment of Assignor's Interest
Feb 4, 2021
From: MARTINEZ-LOI, MARIELLE
To: HELSINN ADVANCED SYNTHESIS SA
Reel/Frame 055145/0529 →
Assignment of Assignor's Interest
Feb 4, 2021
From: GUAINAZZI, ANGELO; GARCIA RUBIO, SILVINA
To: HELSINN THERAPEUTICS (US) INC
Reel/Frame 055145/0553 →
Assignment of Assignor's Interest
Feb 4, 2021
From: GIULIANO, CLAUDIO; PIETRA, CLAUDIO
To: HELSINN HEALTHCARE SA
Reel/Frame 055220/0845 →
Assignment of Assignor's Interest
Jun 8, 2022
From: GARCIA RUBIO, SILVINA; GUAINAZZI, ANGELO
To: HELSINN THERAPEUTICS (US) INC
Reel/Frame 060392/0934 →